Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

Investors knocked $70bn off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Ozempic is a FDA-approved prescription injectable medication that was originally created to treat type 2 diabetes, but is often utilized for weight loss since it helps control cravings and ...

Drugs used for diabetes and weight loss like Ozempic and Wegovy were found to be effective for weight loss when taken as a pill, according to research published over the weekend. Rybelsus is the ...